Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lp(a)”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT05565742
What this trial is testing

LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 320
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Not applicableUnknownNCT05323227
What this trial is testing

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 378
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Large-scale testing (Phase 3)Ended earlyNCT00562016
What this trial is testing

Protect II, A Prospective, Multicenter Randomized Controlled Trial

Who this might be right for
Coronary Artery Disease
Abiomed Inc. 452
Early research (Phase 1)Looking for participantsNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Not applicableStudy completedNCT06892249
What this trial is testing

Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

Who this might be right for
CKDLow Protein Dietary IntakeMalnutrition (Calorie)
Fresenius Kabi Taiwan Ltd. 74
Not applicableNot Yet RecruitingNCT07198009
What this trial is testing

2-HOBA Supplementation in People With Elevated Lipoprotein(a)

Who this might be right for
HyperlipidemiaElevated Lp(a)
The Miriam Hospital 10
Not applicableActive Not RecruitingNCT06304415
What this trial is testing

Elevated Lipoprotein(a) in Hospital Staff

Who this might be right for
HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaCardiovascular Diseases
Changi General Hospital 2,800
Testing effectiveness (Phase 2)Study completedNCT00596726
What this trial is testing

RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study

Who this might be right for
Cardiac Surgery
Abiomed Inc. 17
Large-scale testing (Phase 3)Looking for participantsNCT06875973
What this trial is testing

Pelacarsen Roll-over Extension Program

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 599
Testing effectiveness (Phase 2)Study completedNCT00534859
What this trial is testing

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

Who this might be right for
Patients Undergoing High Risk PCI.
Abiomed Inc. 28
Large-scale testing (Phase 3)Looking for participantsNCT07157774
What this trial is testing

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Who this might be right for
Elevated Lp(a)Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company 10,450
Large-scale testing (Phase 3)Not Yet RecruitingNCT07613294
What this trial is testing

See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Who this might be right for
AtherosclerosisCardiovascular DiseasesLipoprotein(a)
Eli Lilly and Company 252
Testing effectiveness (Phase 2)Study completedNCT05563246
What this trial is testing

LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 233
Testing effectiveness (Phase 2)Looking for participantsNCT07327840
What this trial is testing

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Who this might be right for
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD. 204
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Not applicableLooking for participantsNCT06482476
What this trial is testing

Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study

Who this might be right for
Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students
University of Ioannina 246
Early research (Phase 1)Study completedNCT04606602
What this trial is testing

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

Who this might be right for
HyperlipidemiasDyslipidemiasElevated Lp(a)
Silence Therapeutics plc 70
Load More Results